Skip to main content

Articles

Page 1 of 58

  1. Insulin resistance, liver injury and dyslipidemia are reported in non-alcoholic fat liver disease (NAFLD) patients. Interleukin (IL)-38 may take part in the pathophysiology of insulin resistance. Nevertheless,...

    Authors: Jun Cao, Lin Hua, Shipei Zhang, Jinping Tang, Fan Ke, Zhouhuan Wu and Guohui Xue
    Citation: Lipids in Health and Disease 2022 21:70
  2. Pulmonary arterial hypertension (PAH) is a chronic, progressive lung vascular disease accompanied by elevated pulmonary vascular pressure and resistance, and it is characterized by increased pulmonary artery s...

    Authors: Jingyuan Chen, Jun Luo, Haihua Qiu, Yi Tang, Xiaojie Yang, Yusi Chen, Zilu Li and Jiang Li
    Citation: Lipids in Health and Disease 2022 21:69
  3. Previous studies have shown that at a similar body mass index, Middle Eastern immigrants are more insulin resistant and at higher risk for type 2 diabetes (T2D) than native Europeans. Insulin resistance is str...

    Authors: Karin G. Stenkula, Lisa Esbjörnsson Klemendz, Claes Fryklund, Nils Wierup, Wathik Alsalim, Mona Landin-Olsson, Lena Trinh, Sven Månsson and Louise Bennet
    Citation: Lipids in Health and Disease 2022 21:68
  4. Inflammatory breast cancer (IBC) represents a deadly aggressive phenotype of breast cancer (BC) with a unique clinicopathological presentation and low survival rate. In fact, obesity represents an important ri...

    Authors: Aya Saber Ibrahim, Mohamed El-Shinawi, Salwa Sabet, Sherif Abdelaziz Ibrahim and Mona Mostafa Mohamed
    Citation: Lipids in Health and Disease 2022 21:67
  5. The role of lipid metabolism in obesity and cancer manifestations cannot be underestimated, but whether alterations in lipid metabolism can manipulate the vasculature to promote obesity among breast cancer (BC...

    Authors: Akinkunmi Paul Okekunle, Ga-Eun Yie, Sihan Song, Zisun Kim, Hyun Jo Youn, Jihyoung Cho, Jun Won Min, Yoo Seok Kim and Jung Eun Lee
    Citation: Lipids in Health and Disease 2022 21:66
  6. Familial hypercholesterolemia (FH) is a codominant autosomal disease characterized by high low-density lipoprotein cholesterol (LDLc) and a high risk of premature cardiovascular disease (CVD). The molecular ba...

    Authors: Victoria Marco-Benedí, Ana M. Bea, Ana Cenarro, Estíbaliz Jarauta, Martín Laclaustra and Fernando Civeira
    Citation: Lipids in Health and Disease 2022 21:64
  7. To assess the long-term biological coefficient of variation within individuals (CVI) and between individuals (CVG), effect of aging and cholesterol lowering drugs on blood levels of lipids in HIV-1-infected and -...

    Authors: Najib Aziz, David W. Gjertson, Matthew J. Mimiaga, Chantel D. Azarkman, Rey Soto, Nicole Alexopoulos and Roger Detels
    Citation: Lipids in Health and Disease 2022 21:63
  8. Literature on the association between the atherogenic index of plasma (AIP) and the risk of major adverse cardiovascular events (MACEs) among non-diabetic hypertensive older adults is quite limited.

    Authors: Fei Hang, Jieruo Chen, Zefeng Wang, Keyang Zheng and Yongquan Wu
    Citation: Lipids in Health and Disease 2022 21:62
  9. It is important to identify patients at increased risk of worsening of left ventricular ejection fraction (LVEF) after a myocardial infarction (MI). We aimed to identify the association of various potential bi...

    Authors: Lina S. Silva-Bermúdez, Andrea Vargas-Villanueva, Carlos A. Sánchez-Vallejo, Ana C. Palacio, Andrés F. Buitrago and Carlos O. Mendivil
    Citation: Lipids in Health and Disease 2022 21:61
  10. Trimethylamine N-oxide (TMAO)-related metabolites are associated with the pathogenesis of atherosclerotic cardiovascular disease (ASCVD) and are known to disrupt lipid metabolism. The aims of this study were t...

    Authors: Xiaowei Xiong, Jian Zhou, Qiang Fu, Xiaowei Xu, Shaobin Wei, Shenghua Yang and Buxing Chen
    Citation: Lipids in Health and Disease 2022 21:60
  11. Clinical investigations have found that there was a close association between T2DM and adverse cardiovascular events, with possible mechanisms included inflammation, apoptosis, and lipid metabolism disorders. ...

    Authors: Yufeng Mei, Zhiming Zhao, Yongnan Lyu and Yan Li
    Citation: Lipids in Health and Disease 2022 21:59
  12. The role of serum high-density lipoprotein cholesterol (HDL-c) in tumorigenesis are observed in several endocrine-related cancers. However, its role in pancreatic neuroendocrine neoplasms (PNENs) has not been ...

    Authors: Li Quan, Yongkang Liu, Wenjing Cui, Xinru Wang, Weixiao Zhang, Zhongqiu Wang, Chuangen Guo, Chao Lu, Feixiang Hu and Xiao Chen
    Citation: Lipids in Health and Disease 2022 21:58
  13. The incidence rate of metabolic-associated fatty liver disease (MAFLD) is increasing annually; however, there are still no effective methods for establishing an early diagnosis and conducting real-time tracing...

    Authors: Yuqing Zhu, Yani Ke, Yijie Hu, Kaihan Wu, Shan Liu and Jie Hu
    Citation: Lipids in Health and Disease 2022 21:57
  14. Heterozygous familial hypercholesterolemia (HeFH) due to low-density lipoprotein receptor (LDLR) mutations predisposes patients to highly elevated levels of cholesterol, and patients are at increased risk of a...

    Authors: Kasper Aalbæk Kjærgaard, Sixten Harborg, Henrik Kjærulf Jensen and Signe Borgquist
    Citation: Lipids in Health and Disease 2022 21:56
  15. The triglyceride and glucose index (TyG) and triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) are substitute markers of insulin resistance (IR). In a retrospective cross-sectional study, t...

    Authors: Zhi Liu, He He, Yuzhao Dai, Lidan Yang, Shenling Liao, Zhenmei An and Shuangqing Li
    Citation: Lipids in Health and Disease 2022 21:55
  16. MicroRNAs (MiRNAs) are known to participate in preadipocyte differentiation, but the manner in which miR-146a-5p participates in this process remains unclear. This study was performed to examine the participat...

    Authors: Yifen Wang, Jie Zhang, Xueru Chu, Mengke Wang, Yongning Xin and Shousheng Liu
    Citation: Lipids in Health and Disease 2022 21:54
  17. An excessive rise in maternal lipids during pregnancy may have detrimental impacts on maternal and fetal health leading to adverse pregnancy outcomes. However, knowledge gaps exist with respect to the associat...

    Authors: Todd C. Rideout, Xiaozhong Wen, Divya Choudhary, Marissa Catanzaro, Richard W. Browne, Vanessa M. Barnabei and Kai Ling Kong
    Citation: Lipids in Health and Disease 2022 21:53
  18. The severity of metabolic dysfunction-associated fatty liver disease (MAFLD) reportedly plays a part in the etiology of colorectal tumors. However, there is no consensus.

    Authors: Yunqing Zeng, Ruyue Cao, Ziwen Tao and Yanjing Gao
    Citation: Lipids in Health and Disease 2022 21:52
  19. Preeclampsia (PE) is a multisystemic syndrome specific to pregnancy. Although PE is the leading cause of death from complications associated with pregnancy, its aetiology is still unknown. In PE, lipid metabol...

    Authors: LA Gil-Acevedo, Guillermo Ceballos and YD Torres-Ramos
    Citation: Lipids in Health and Disease 2022 21:51
  20. Hypertriglyceridemic-waist (HTGW) phenotype has been proposed as a practical tool for screening the risk of cardiovascular diseases and glycemic metabolic disease. This study sought to investigate the relation...

    Authors: Ming Yang, Yaqin Xu, Chong Hu, Shuhua Zhang, Maobin Kuang and Yang Zou
    Citation: Lipids in Health and Disease 2022 21:50
  21. The association of serum triglyceride (TG) levels with the severity of hypertriglyceridaemia-induced acute pancreatitis (HTG-AP) remains controversial. This study aimed to comprehensively assess the TG levels ...

    Authors: Xiuli Dong, Shuang Pan, Daguan Zhang, Wandong Hong, Tanzhou Chen, Bingxin Zhang, Zhiming Huang and Chengshui Chen
    Citation: Lipids in Health and Disease 2022 21:49
  22. The preventive effect of cholesterol efflux capacity (CEC) on the progression of atherosclerotic lesions has been confirmed in animal models, but findings in the population are inconsistent. Therefore, this me...

    Authors: Wenke Cheng, Maciej Rosolowski, Julia Boettner, Steffen Desch, Alexander Jobs, Holger Thiele and Petra Buettner
    Citation: Lipids in Health and Disease 2022 21:47
  23. Hepatocyte nuclear factor 4α (HNF4α) and glucocorticoid receptor (GR), master regulators of liver metabolism, are down-regulated in fatty liver diseases. The present study aimed to elucidate the role of down-r...

    Authors: Hong Lu, Xiaohong Lei, Rebecca Winkler, Savio John, Devendra Kumar, Wenkuan Li and Yazen Alnouti
    Citation: Lipids in Health and Disease 2022 21:46
  24. Obesity, especially presenting with excessive amounts of visceral adipose tissue (VAT), is strongly associated with insulin resistance (IR), atherosclerosis, metabolic syndrome, and cardiovascular diseases (CV...

    Authors: Xuan Song, Hongxia Wu, Wenhua Zhang, Bei Wang and Hongjun Sun
    Citation: Lipids in Health and Disease 2022 21:45
  25. Low-density lipoprotein:high-density lipoprotein cholesterol ratio (LDL:HDL ratio) has a good performance in identifying diabetes mellitus (DM) and insulin resistance. However, it is not yet clear whether the ...

    Authors: Maobin Kuang, Nan Peng, Jiajun Qiu, Yanjia Zhong, Yang Zou and Guotai Sheng
    Citation: Lipids in Health and Disease 2022 21:44
  26. Monoacetyldiglycerides (MAcDG), are acetylated triglycerides (TG) and an emerging class of bioactive or functional lipid with promising nutritional, medical, and industrial applications. A major challenge exis...

    Authors: Charles F. Manful, Thu H. Pham, Heather Spicer and Raymond H. Thomas
    Citation: Lipids in Health and Disease 2022 21:42
  27. This review focuses on antisense oligonucleotides and small interfering ribonucleic acid therapies approved or under development for the management of lipid disorders. Recent advances in RNA-based therapeutics...

    Authors: Dirk Jacobus Blom, Adrian David Marais, Rajen Moodley, Nico van der Merwe, Alet van Tonder and Frederick Johan Raal
    Citation: Lipids in Health and Disease 2022 21:41
  28. Sciadonic acid (SA) is an anti-inflammatory fatty acid displacing arachidonic acid (ARA) from specific phospholipid pools, thus modulating downstream pro-inflammatory lipid mediators. Its novel anti-inflammato...

    Authors: Alvin Berger
    Citation: Lipids in Health and Disease 2022 21:40
  29. Low-density lipoprotein cholesterol (LDL-C) is an important cardiovascular disease marker that is used to estimate the risk of acute coronary syndrome in patients. The Sampson equation is an accurate LDL-C equ...

    Authors: Jiayu Li, Yanguo Xin, Jingye Li, Meng Meng, Li Zhou, Hui Qiu, Hui Chen and Hongwei Li
    Citation: Lipids in Health and Disease 2022 21:39
  30. It is unclear why primary nephrotic syndrome (PNS) patients often have dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an important regulator of lipid metabolism. In this ...

    Authors: Fu Zhong, Shurao Liu, Yue Li, Guanyu Li, Ming Liu, Jingzhi Wang, Weijing Cui, Yanhong Suo and Xia Gao
    Citation: Lipids in Health and Disease 2022 21:38
  31. Authors: Antonietta Stellavato, Anna Virginia Adriana Pirozzi, Francesca de Novellis, Ilaria Scognamiglio, Valentina Vassallo, Andrea Maria Giori, Mario De Rosa and Chiara Schiraldi
    Citation: Lipids in Health and Disease 2022 21:37

    The original article was published in Lipids in Health and Disease 2018 17:24

  32. The association between serum uric acid (SUA) and the components of dyslipidaemia and their dose-response relationships have not been thoroughly explored. This study assessed the relationship between SUA and e...

    Authors: Lian Peng, Leilei Liu, Nana Ma, Fan Yang, Chan Nie, Tingting Yang, Qibing Zeng, Ziyun Wang, Degan Xu, Lu Ma, Yuyan Xu and Feng Hong
    Citation: Lipids in Health and Disease 2022 21:36
  33. Although high serum cholesterol is widely recognized as a major risk factor for heart disease, the health effects of low cholesterol are less clear. Several studies have found a correlation between low cholest...

    Authors: Qun Zhang, Ziping Liu, Qian Wang and Xiaoqian Li
    Citation: Lipids in Health and Disease 2022 21:35
  34. Dyslipidemia is a significant contributor to cardiovascular and cerebrovascular diseases. Research on the relationship between breakfast consumption frequency and dyslipidemia in the working population is lack...

    Authors: Qi-mei Li, Cheng-kai Wu, Peng-cheng Ma, Hao Cui, Rui-ning Li, Chang Hong, Lin Zeng, Sheng-wu Liao, Lu-shan Xiao, Li Liu and Wen-yuan Li
    Citation: Lipids in Health and Disease 2022 21:33
  35. Recent findings show that extracellular vesicle constituents can exert short- and long-range biological effects on neighboring cells in the brain, opening an exciting avenue for investigation in the field of n...

    Authors: Melissa R. Pergande, Christina Kang, Diann George, Pearl A. Sutter, Stephen J. Crocker, Stephanie M. Cologna and Maria I. Givogri
    Citation: Lipids in Health and Disease 2022 21:32
  36. Omega 3 polyunsaturated fatty acids (n-3 PUFA) are known to have beneficial effects on cardiovascular and metabolic health. However, whether different sources of n-3 PUFA, for instance fatty fish vs vegetable ...

    Authors: Pasquale Mone, Fahimeh Varzideh, Urna Kansakar, Carmine Infante, Angela Lombardi, Antonio de Donato, Salvatore Frullone and Gaetano Santulli
    Citation: Lipids in Health and Disease 2022 21:31
  37. Elevated monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) is relevant to higher all-cause and cardiovascular mortality in patients with coronary artery disease and other comorbidities. However, the...

    Authors: Ming Jiang, Jiaming Yang, Huayiyang Zou, Menghuan Li, Wei Sun and Xiangqing Kong
    Citation: Lipids in Health and Disease 2022 21:30
  38. Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. The fat mass and obesity–associated protein (FTO) has been shown to be involved in obesity; however, its role in NAF...

    Authors: Xiaohui Wei, Jielei Zhang, Min Tang, Xuejiao Wang, Nengguang Fan and Yongde Peng
    Citation: Lipids in Health and Disease 2022 21:29
  39. Conflicting results on the prognostic value of the visceral adiposity index (VAI) in patients with metabolic-associated fatty liver disease (MAFLD) have been reported. This study aimed to assess the diagnostic...

    Authors: Xianhao Yi, Shaihong Zhu and Liyong Zhu
    Citation: Lipids in Health and Disease 2022 21:28
  40. Chemerin is a brand-new adipokine that has been linked to both inflammation and metabolic dysfunction. Even though a rising number of studies have connected chemerin to metabolic-associated fatty liver disease...

    Authors: Qian Ren, Hongya Wang, Yan Zeng, Xia Fang, Mei Wang, Dongze Li, Wei Huang and Yong Xu
    Citation: Lipids in Health and Disease 2022 21:27
  41. Gallstone disease (GSD) is a common and costly biliary disorder. Multiple studies have investigated the associations between blood lipid metabolism and GSD risk; however, the results are inconsistent. This res...

    Authors: Min Zhang, Min Mao, Chi Zhang, Fulan Hu, Ping Cui, Guangcan Li, Jia Shi, Xin Wang and Xuefeng Shan
    Citation: Lipids in Health and Disease 2022 21:26
  42. The relationship of consumption of dietary fat and fatty acids with esophageal squamous cell carcinoma (ESCC) risk remains unclear. This study aimed to explore the relationship of dietary fat and fatty acids i...

    Authors: Yu-Xuan Tang, Wenjing Zhao, Jun Li, Peng Xie, Shuyi Wang, Lubin Yan, Xiangbing Xing, Jiahai Lu, Lap-Ah Tse, Harry Hao-Xiang Wang and Xudong Liu
    Citation: Lipids in Health and Disease 2022 21:25
  43. Obesity and diabetes are two chronic metabolic diseases whose prevalence is increasing at an alarming rate globally. A close association between obesity, diabetes, and insulin resistance has been identified, a...

    Authors: Shahanas Chathoth, Mona H. Ismail, Hanan M. Alghamdi, Hazem Mohamed Zakaria, Khairi Ahmed Hassan, Saeed Alshomimi, Chittibabu Vatte, Cyril Cyrus, Hind S. Alsaif, Ahmed Mostafa, Heba Shaaban and Amein Al Ali
    Citation: Lipids in Health and Disease 2022 21:24
  44. Relatively little is known about the physiological whole blood fatty acid composition in young people. Likewise, few studies have addressed the question of correlations between Mediterranean diet (MedDiet) adh...

    Authors: Marie-Louise Syrén, Stefano Turolo, Erika Adalgisa de Marco, Valentina De Cosmi, Patrizia Risé, Franca Marangoni, Dario Guido Minoli, Gianantonio Manzoni and Carlo Agostoni
    Citation: Lipids in Health and Disease 2022 21:23
  45. Colorectal cancer (CRC) is one of the most common cancers worldwide characterized by disparities in age, gender, race and anatomic sites. The mechanism underlying pathogenesis, progression and disparities of C...

    Authors: Zhirong Liu, Christian R. Gomez, Ingrid Espinoza, Thuy Phuong T. Le, Veena Shenoy and Xinchun Zhou
    Citation: Lipids in Health and Disease 2022 21:22
  46. The prevalence of hypertriglyceridemia has been increasing worldwide. Attention is drawn to the fact that the frequency of a special hypertriglyceridemia entity, named chylomicronemia syndrome, is variable amo...

    Authors: György Paragh, Ákos Németh, Mariann Harangi, Maciej Banach and Péter Fülöp
    Citation: Lipids in Health and Disease 2022 21:21

Annual Journal Metrics